Viewing StudyNCT00239252



Ignite Creation Date: 2024-05-05 @ 12:04 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00239252
Status: COMPLETED
Last Update Posted: 2014-08-26
First Post: 2005-09-13

Brief Title: Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis C
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2005-09-13
First Submit QC Date: October 13 2005
Study First Post Date: 2005-10-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-08-25
Last Update Post Date: 2014-08-26
Last Update Post Date Type: ESTIMATED